Cargando…
The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines
Introduction: Optimal treatment of dyslipidemia is a top priority in the prevention of cardiovascular diseases. For this purpose, clinicians in Iran usually refer to four current international guidelines. The aim of this study was to assess the approach of Iranian clinical pharmacists in the treatme...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278195/ https://www.ncbi.nlm.nih.gov/pubmed/37342668 http://dx.doi.org/10.34172/jcvtr.2023.31585 |
_version_ | 1785060432588832768 |
---|---|
author | Mirshekari, Mehrzad Shirzad, Nooshin Hemmatabadi, Mahboobeh Namazi, Soha |
author_facet | Mirshekari, Mehrzad Shirzad, Nooshin Hemmatabadi, Mahboobeh Namazi, Soha |
author_sort | Mirshekari, Mehrzad |
collection | PubMed |
description | Introduction: Optimal treatment of dyslipidemia is a top priority in the prevention of cardiovascular diseases. For this purpose, clinicians in Iran usually refer to four current international guidelines. The aim of this study was to assess the approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines. Methods: A structured questionnaire was prepared. Questions (n=24) included the demographics (n=7), dyslipidemia references (n=3), dyslipidemia general knowledge of respondents (n=10), and questions (n=4) designed based on the difference among the latest version of guidelines participants stated they use in their practice. After validity conformation, the questionnaire was distributed to 120 clinical pharmacists, electronically from May to August 2021. Results: Response rate was 77.5% (n=93). The majority of participants (80.6%, n=75) claimed to have used the 2018 ACC/AHA guideline. The Median (interquartile range [IQR]) score of the general knowledge questions was 5.0 (2.0) out of 10. The Median (IQR) score of questions designed based on the difference among guidelines was calculated 3(1) out of 4. There was no significant (P=0.25) difference in score among participants according to their guideline selection. Moreover, the gender and length of experience as a clinical pharmacist had no significant (P>0.05) effect on the score of participants. Conclusion: In this study, Iranian clinical pharmacists answered half of the dyslipidemia general knowledge questions correctly. Also, Participants were up-to-date on 75% of the questions designed based on the latest version of the guideline they had been using in their practice. |
format | Online Article Text |
id | pubmed-10278195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Tabriz University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-102781952023-06-20 The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines Mirshekari, Mehrzad Shirzad, Nooshin Hemmatabadi, Mahboobeh Namazi, Soha J Cardiovasc Thorac Res Original Article Introduction: Optimal treatment of dyslipidemia is a top priority in the prevention of cardiovascular diseases. For this purpose, clinicians in Iran usually refer to four current international guidelines. The aim of this study was to assess the approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines. Methods: A structured questionnaire was prepared. Questions (n=24) included the demographics (n=7), dyslipidemia references (n=3), dyslipidemia general knowledge of respondents (n=10), and questions (n=4) designed based on the difference among the latest version of guidelines participants stated they use in their practice. After validity conformation, the questionnaire was distributed to 120 clinical pharmacists, electronically from May to August 2021. Results: Response rate was 77.5% (n=93). The majority of participants (80.6%, n=75) claimed to have used the 2018 ACC/AHA guideline. The Median (interquartile range [IQR]) score of the general knowledge questions was 5.0 (2.0) out of 10. The Median (IQR) score of questions designed based on the difference among guidelines was calculated 3(1) out of 4. There was no significant (P=0.25) difference in score among participants according to their guideline selection. Moreover, the gender and length of experience as a clinical pharmacist had no significant (P>0.05) effect on the score of participants. Conclusion: In this study, Iranian clinical pharmacists answered half of the dyslipidemia general knowledge questions correctly. Also, Participants were up-to-date on 75% of the questions designed based on the latest version of the guideline they had been using in their practice. Tabriz University of Medical Sciences 2023 2023-03-16 /pmc/articles/PMC10278195/ /pubmed/37342668 http://dx.doi.org/10.34172/jcvtr.2023.31585 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Mirshekari, Mehrzad Shirzad, Nooshin Hemmatabadi, Mahboobeh Namazi, Soha The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines |
title | The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines |
title_full | The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines |
title_fullStr | The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines |
title_full_unstemmed | The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines |
title_short | The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines |
title_sort | approach of iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278195/ https://www.ncbi.nlm.nih.gov/pubmed/37342668 http://dx.doi.org/10.34172/jcvtr.2023.31585 |
work_keys_str_mv | AT mirshekarimehrzad theapproachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines AT shirzadnooshin theapproachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines AT hemmatabadimahboobeh theapproachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines AT namazisoha theapproachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines AT mirshekarimehrzad approachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines AT shirzadnooshin approachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines AT hemmatabadimahboobeh approachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines AT namazisoha approachofiranianclinicalpharmacistsinthetreatmentofdyslipidemiabasedoninternationalguidelines |